MSI Stryker post

Stryker is leading the category with recent OrthoSensor acquisition

With artificial intelligence (AI) and machine learning emerging out of autonomous vehicles, virtual assistants and smartphones into the healthcare arena, there is a now major shift towards data-driven smart devices for medical implants.

These include expanding the role of smart sensor technologies in orthopedics, specifically the use of intraoperative sensors, wearables and smart implants.

Stryker is one of the medical device leaders making waves in this category with the recent acquisition of OrthoSensor, a provider of sensor technology for use in total joint replacement procedures.

How This Will Propel Stryker

Since 2011, Stryker has been using OrthoSensor’s Verasense intraoperative sensor with its Triathlon Knee System, and will further propel the use of data-driven solutions.

“Smart devices and implants will play a big role in orthopedics and we are excited for OrthoSensor to join Stryker as we continue to innovate and advance smart sensor technologies, including intraoperative sensors, wearables and smart implants across our joint replacement business,” said Spencer Stiles, Stryker’s Group President, Orthopedics and Spine, in this press release. “Patient recovery will become more active as real-time measurement on key performance insights drive improved outcomes and patient satisfaction.”

This new offering is also complementary to Stryker’s category Mako SmartRobotics solution, which will enhance the robotic workflow through one complete data-driven feedback mechanism.

Medical Device Manufacturers Catching Up to the Technology

According to a 2019 Orthopedic Design & Technology article, medical implant technologies have remained relatively the same, while the innovations surrounding implants have rapidly transformed.  Many of these innovations include devices that employ neuromuscular electrical stimulation (NMES), as well as 3D motion capture for physical therapy.

With Stryker’s acquisition of OrthoSensor, it is leading the sector into a new era where the most cutting-edge, data-driven solutions are integrated with a wide-range of implants.

Impact on the Quality of Care

According to a 2019 study by the National Institutes of Health (NIH) and Binghamton University, knee implants with data-driven, sensor technologies can ultimately reduce the number of knee-replacement surgeries overall.

In addition to this cost-savings benefit, this study shows how smart implants in orthopedic surgery can also improve overall patient outcomes. Specifically, patients equipped with smart implants have a lower risk of serious infection post-op, suffer from less discomfort and pain, and could also be less likely to need revision surgeries in the future.

The future of smart implants is finally upon us – where real-time data and analytics is driving cost reductions and better care overall. Stryker’s acquisition of OrthoSensor will pave the way for other medical device and implant providers to join this exciting frontier.

In addition, this begs a bigger question:  Are patients ready to embrace these kinds of innovations?  In the coming weeks, we will be exploring this topic further with an exclusive MSI International study that will measure patient sentiment when it comes to smart devices and implants.

For any medical device manufacturer looking to expand their smart implant offerings, MSI offers comprehensive market research solutions that can pave the way for future success in this arena.  Please contact us here to learn more.